Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
25 NC counties are under alert, including Northampton County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
158.19
+0.23 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,293,907
Open
158.20
Bid (Size)
158.26 (5)
Ask (Size)
158.48 (6)
Prev. Close
157.96
Today's Range
158.11 - 158.84
52wk Range
144.95 - 175.97
Shares Outstanding
2,628,679,824
Dividend Yield
3.01%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Value Stocks to Buy on the Dip: March 2024
Today 14:46 EDT
With money rotating away from risk-on enterprises, investors ought to pivot and consider value stocks to buy.
Via
InvestorPlace
Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling
Today 12:58 EDT
Johnson & Johnson faces legal scrutiny over talc-cancer link. Recent rulings could impact 53,000+ lawsuits. Learn more about the $700 million settlement and evolving evidence in this ongoing...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Performance
YTD
-1.11%
-1.11%
1 Month
-1.62%
-1.62%
3 Month
+1.18%
+1.18%
6 Month
+0.69%
+0.69%
1 Year
+4.20%
+4.20%
More News
Read More
3 Dividend Stocks That Are Likely to Raise Their Payouts in April
Today 6:15 EDT
Via
The Motley Fool
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
March 27, 2024
Via
Benzinga
Shockwave Medical Stock Sees Relative Strength Rating Ride Higher
March 27, 2024
Via
Investor's Business Daily
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
March 25, 2024
Via
Benzinga
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 27, 2024
Via
Benzinga
7 Dow Stocks to Buy on the Dip: March 2024
March 27, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
What's Going On With Shockwave Medical Stock?
March 26, 2024
Via
Benzinga
7 Dividend Aristocrats That Can Safeguard Your Income Through Any Crisis
March 26, 2024
Via
InvestorPlace
Elliott Wave Technical Analysis: Johnson & Johnson - Tuesday, March 26
March 26, 2024
Via
Talk Markets
Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships
March 25, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500
March 25, 2024
Via
InvestorPlace
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Dividend Stock Watch List: April 2024 Edition
March 24, 2024
Via
Talk Markets
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 Dividend Darlings to Scoop Up Every Time the Market Dips
March 24, 2024
Via
InvestorPlace
3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff
March 22, 2024
Via
InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
March 22, 2024
Via
The Motley Fool
Wall Street’s Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich
March 21, 2024
Via
InvestorPlace
Johnson & Johnson's Abiomed Unit Recalls Instructions For Some Impella Blood Pumps Due To Cutting Risks
March 21, 2024
Via
Benzinga
Topics
Death
Product Recall
Exposures
Death
Legal
Product Safety
Dear 3M Stock Fans, Mark Your Calendars for April 1
March 21, 2024
Via
InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
March 21, 2024
Via
Benzinga
Should You Buy 3M Before April 1?
March 21, 2024
Via
The Motley Fool
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
March 20, 2024
Via
Benzinga
Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities'
March 19, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.